IM Cannabis Announces Intention to Complete 3:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
PR Newswire•18/11/2026•16:01 ET
3
Key Highlights
- ➤3:1 share consolidation approved, targeting November 23, 2026 effectiveness
- ➤Shares expected to fall from 1,844,162 to approximately 614,721
- ➤Consolidation seeks Nasdaq US$1.00 minimum bid-price compliance
- ➤IMC previously completed a 30:1 consolidation on August 27, 2026
- ➤Below US$1.00 for 30 consecutive business days could trigger delisting determination
IM Cannabis Announces Intention to Complete 3:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance PR Newswire
VANCOUVER and GLIL YAM, Israel, Nov. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every three pre-consolidated Common Shares (the "Consolidation").
Get started
Create a free account to read the full story.
